XML 15 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Statement of Cash Flows [Abstract]              
Net loss for the period $ (6,939) $ (12,134) $ (13,897) $ (10,829) $ (28,387) $ (17,582)  
Items not involving cash:              
Depletion, depreciation and amortization         921 3,480  
Stock-based compensation         2,498 2,241  
Change in value of convertible debentures (940)   1,455   (447) 1,135  
Change in value of warrant liabilities         (3,281) 3,802  
Accretion of asset retirement obligation 484   459   1,478 1,376 $ 1,835
Unrealized foreign exchange (gains) losses         142 (447)  
Impairment of inventories 2,330   714   8,412 3,063  
Revision of asset retirement obligation         151 0  
Impairment of mineral properties held for sale         0 0  
Acquisition of royalty interests, net of share issuance costs         0 3,622  
Other non-cash expenses         2,367 392  
Changes in assets and liabilities              
Increase in inventories         (12,854) (214)  
Decrease (increase) in trade and other receivables         234 (145)  
Increase in prepaid expenses and other assets         (236) (760)  
Decrease in accounts payable and accrued liabilities         (2,688) (2,678)  
Cash paid for reclamation and remediation activities         0 (225)  
Changes in deferred revenue         (2,724) 2,434  
Net cash (used in) provided by operating activities         (34,698) 388  
INVESTING ACTIVITIES              
Purchase of mineral properties and plant, property and equipment         0 (55)  
Maturities and sales of marketable securities         19,530 2,565  
Maturities and sales of marketable securities         0 2,940  
Purchase of available for sale investments         0 (25,525)  
Net cash (used in) provided by investing activities         19,530 (20,075)  
FINANCING ACTIVITIES              
Issuance of common shares for cash, net of issuance cost         14,696 25,638  
Proceeds from notes payable         0 (914)  
Proceeds from Collection of Notes Receivable         0 500  
Repayment of loans and borrowings         (79) (10,855)  
Cash received from exercise of warrants         5 366  
Cash received from exercise of stock options         146 619  
Cash received from non-controlling interest         46 0  
Cash received for notes receivable         801 0  
Net cash (used in) provided by financing activities         15,615 15,354  
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH DURING THE PERIOD         447 (4,333)  
Effect of exchange rate fluctuations on cash held in foreign currencies         43 (38)  
Cash, cash equivalents and restricted cash - beginning of period   $ 34,292   $ 40,701 34,292 40,701 40,701
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - END OF PERIOD $ 34,782   $ 36,330   34,782 36,330 $ 34,292
Supplemental disclosure of cash flow information:              
Interest         1,110 1,008  
Warrant liability transferred to equity upon exercise         $ 2 $ 0